Click it and Unblock the Notifications
Latest Updates
-
Who Is Sayali Surve? Miss India Earth Winner Reconverts To Hinduism After Alleged Harassment In Marriage -
Viral Kumbh Mela Girl Monalisa Elopes With Boyfriend, Reaches Kerala Police — Did The Couple Secretly Marry? -
Who Is Harish Rana? Supreme Court’s Landmark Passive Euthanasia Ruling For Man In Coma For 13 Years -
Mohit Chauhan Birthday Special: 7 Iconic Songs For Every Mood—Love, Heartbreak And Wanderlust -
No Smoking Day 2026: Trying To Quit Smoking? This Simple 3-3-3 Rule Helps Fight Cigarette Cravings -
Sheetala Ashtami 2026: Significance, Puja Timings, Rituals And The Meaning Behind The Basoda Tradition -
Horoscope for Today March 11, 2026 - Small Choices, Steady Progress -
Vijay Deverakonda, Rashmika Mandanna’s Pradhanam-Mehendi Looks Redefine Celebrity Wedding Fashion This Year -
Lucky Colours For March 2026 According To Zodiac Signs And The Shades You Should Wear -
Randeep Hooda Becomes Father On His Dad’s Birthday, Shares First Baby Photos In Heartwarming Instagram Post
COVID-19 Vaccination: Supply, Eligibility Will Decide Vax For Kids
The government will take a final decision on vaccinating children and adolescents against coronavirus on the basis of overall scientific rationale as well as the supply situation of vaccines available for those below 18 years, Covid task force chief V K Paul said on Sunday.
Paul also cautioned that even though infections were coming down and the second wave was subsiding, it would not be fair to say that the worst was over since many countries had seen more than two waves.
Currently, three vaccines - Covishield, Covaxin and Sputnik V - being administered in the country are only for those above 18. Zydus Cadila's needle-free vaccine ZyCoV-D is set to become the first that will be available in India for those between 12 and 18. It has received emergency use authorisation (EUA).
"We do know several countries have introduced vaccination for adolescents and children. We will make a final decision based on the overall scientific rationale and the supply situation of the child-licenced vaccines," Paul said.
An expert panel of India's central drug authority has recommended granting EUA to Bharat Biotech's Covaxin for children and adolescents in the 2-18 age group with certain conditions.
According to Paul, Covaxin is part of the adult vaccination programme and how to provide the vaccine, if at all for children, has to be also examined.
"A pragmatic decision can be taken (only) by balancing the supply and the potential eligibility," he said.
Paul said: "The preparation for incorporation of Zydus Cadila's vaccine into the vaccination programme is proceeding well, training is already being held."
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google